Evidence map›Paper›PMID 32375972›Full record

ArticleMicrobial genomics2020

Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of

Ines Bleriot, Rocío Trastoy, Lucia Blasco, Felipe Fernández-Cuenca, Antón Ambroa, Laura Fernández-García, Olga Pacios, Elena Perez-Nadales, Julian Torre-Cisneros, Jesús Oteo-Iglesias and 6 more

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Phenotypic and genome-based characterization ofFrontiers in microbiology · 2026
    Article
  5. The Potential Roles of Prophages in the Pathogenicity ofAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Characterization and Diversity ofInternational journal of molecular sciences · 2023
    Article
  12. NDM-5-carrying3 Biotech · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Analysis of intact prophages in genomes ofFrontiers in microbiology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Ines BleriotMicrobiology Department, Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain.
Rocío TrastoyMicrobiology Department, Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain.
Lucia BlascoMicrobiology Department, Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain.
Felipe Fernández-CuencaStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid.
Antón AmbroaMicrobiology Department, Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain.
Laura Fernández-GarcíaMicrobiology Department, Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain.
Olga PaciosMicrobiology Department, Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain.
Elena Perez-NadalesSpanish Network for the Research in Infectious Diseases, REIPI, Seville, Spain.
Julian Torre-CisnerosSpanish Network for the Research in Infectious Diseases, REIPI, Seville, Spain.
Jesús Oteo-IglesiasStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid.
Ferran NavarroStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid.
Elisenda MiróStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid.
Alvaro PascualStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid.
German BouMicrobiology Department, Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain.
Luis Martínez-MartínezStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid.
Maria TomasMicrobiology Department, Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain.
Universidade da Coruña · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESHospital Universitario Virgen Macarena · ESUniversitat Autònoma de Barcelona · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial Proteinsbeta-LactamasesComputational BiologyDrug Resistance, Multiple, BacterialEvolution, MolecularGenome SizeGenome, ViralHumansKlebsiella InfectionsKlebsiella pneumoniaeMolecular Sequence AnnotationMultilocus Sequence TypingPhylogenyProphagesBacterial Proteinsbeta-Lactamasescarbapenemasebioinformaticscomparative genomicsgenomic analysisKlebsiella pneumoniaephylogenyprophages

Identifiers

PMID32375972
PMCPMC7371120
OpenAlexW3021390562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.